GlassScriptPhysician profile
Joshua Leek
NPI 1508245911
$1,560.37
in general payments reported to CMS, 2019-2025
15 companies · $27.28 in 2025
The $27.28 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $591 · 2022: $324 · 2023: $584 · 2024: $34.76 · 2025: $27.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $621.44 | 2021-2023 | |
| Getinge USA Sales, LLC | $359.52 | 2021-2023 | Vasoview Hemopro 2 |
| Bayer Healthcare Pharmaceuticals INC. | $126.39 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $82.14 | 2021-2023 | Xarelto |
| Endologix LLC | $76.97 | 2021-2024 | Ovation Ix Iliac Stent Graft, Torus Stent Graft System, Endocross Device |
| Edwards Lifesciences Corporation | $51.93 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $42.46 | 2021 | |
| W. L. Gore & Associates, INC. | $38.43 | 2021-2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Calliditas Therapeutics US INC. | $31.90 | 2022 | |
| Atricure, INC. | $27.28 | 2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Baxter Healthcare | $23.95 | 2023 | Renal - Extraneal Solution |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.49 | 2021 | |
| Amgen INC. | $20.30 | 2024 | Tavneos |
| Alexion Pharmaceuticals, INC. | $20.00 | 2022 | |
| Horizon Therapeutics Plc | $15.17 | 2023 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Leek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.